• No results found

University of Groningen ADHD & Addiction van Emmerik-van Oortmerssen, Katelijne

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen ADHD & Addiction van Emmerik-van Oortmerssen, Katelijne"

Copied!
7
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

ADHD & Addiction

van Emmerik-van Oortmerssen, Katelijne

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2018

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

van Emmerik-van Oortmerssen, K. (2018). ADHD & Addiction: Prevalence, diagnostic assessment and treatment of ADHD in substance use disorder patients. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)
(3)
(4)

245

List Of Publications

Publications in international peer-reviewed journals:

Crunelle CL, Veltman DJ, Booij J, Emmerik-van Oortmerssen K, van den Brink W. Substrates

of neuropsychological functioning in stimulant dependence: a review of functional neuroimaging research. Brain Behav. 2012;2(4):499-523.

van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, Smit F, Crunelle CL,

Swets M, Schoevers RA. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis. Drug Alcohol Depend. 2012;122(1-2):11-19.

Crunelle CL, van den Brink W, Veltman DJ, van Emmerik-van Oortmerssen K, Dom G,

Schoevers RA, Booij J. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence. Eur Neuropsychopharmacol. 2013;23(12):1714-23.

Crunelle CL, Veltman DJ, van Emmerik-van Oortmerssen K, Booij J, van den Brink W.

Impulsivity in adult ADHD patients with and without cocaine dependence. Drug Alcohol

Depend. 2013;129(1-2):18-24.

van de Glind G, van den Brink W, Koeter MW, Carpentier PJ, van Emmerik-van Oortmerssen K, Kaye S, Skutle A, Bu ET, Franck J, Konstenius M, Moggi F, Dom G, Verspreet S, Demetrovics

Z, Kapitany-Foveny M, Fatseas M, Auriacombe M, Schillinger A, Seitz A, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Barta C, Schoevers RA, Group IR, Levin FR. Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug Alcohol Depend. 2013;132(3):587-596.

van de Glind G*, van Emmerik-van Oortmerssen K*, Carpentier PJ, Levin FR, Koeter MW,

Kaye S, Skutle A, Franck J, Konstenius M, Bu ET, Moggi F, Dom G, Demetrovics Z, Fatséas M, Auriacombe M, Schillinger A, Kapitány-Fövény M, Verspreet S, Seitz A, Johnson B, Faraone SV, Casas M, Ramos-Quiroga JA,Allsop S, Carruthers S, Barta C, Schoevers RA,IASP research group, van den Brink W. The international ADHD in Substance use disorders Prevalence (IASP) study: background, methods and study population. Int J Methods Psychiatr Res. 2013;22(3):232-244.

van Emmerik-van Oortmerssen K, Vedel E, Koeter MW, de Bruijn K, Dekker JJ, van den

Brink W, Schoevers RA. Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial. BMC Psychiatry. 2013;13:132.

Swets M, Dekker J, van Emmerik-van Oortmerssen K, Smid GE, Smit F, de Haan L,

Schoevers RA. The obsessive compulsive spectrum in schizophrenia, a meta-analysis and meta-regression exploring prevalence rates. Schizophr Res. 2014;152(2-3):458-468.

(5)

246 Part V | APPENDIX

van de Glind G, Konstenius M, Koeter MW, van Emmerik-van Oortmerssen K, Carpentier

PJ, Kaye S, Degenhardt L, Skutle A, Franck J, Bu ET, Moggi F, Dom G, Verspreet S, Demetrovics Z, Kapitany-Foveny M, Fatseas M, Auriacombe M, Schillinger A, Moller M, Johnson B, Faraone SV, Ramos-Quiroga JA, Casas M, Allsop S, Carruthers S, Schoevers RA, Wallhed S, Barta C, Alleman P, Levin FR, van den Brink W. Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug Alcohol Depend. 2014;134:158-166.

van Emmerik-van Oortmerssen K*, van de Glind G*, Koeter MW, Allsop S, Auriacombe

M, Barta C, Bu ET, Burren Y, Carpentier PJ, Carruthers S, Casas M, Demetrovics Z, Dom G, Faraone SV, Fatseas M, Franck J, Johnson B, Kapitany-Foveny M, Kaye S, Konstenius M, Levin FR, Moggi F, Moller M, Ramos-Quiroga JA, Schillinger A, Skutle A, Verspreet S, IASP Research Group, van den Brink W, Schoevers RA. Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction. 2014;109(2):262-272.

Skutle A, Bu ETH, Jellestad FK, van Emmerik-van Oortmerssen K, Dom G, Verspreet S,

Carpentier PJ, Ramos-Quiroga JA, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, Auriacombe M, Johnson B, Faraone SV, Levin FR, Allsop S, Carruthers S, Schoevers RA, Koeter MWJ, van den Brink W, Moggi F, Møller M, van de Glind G. Early developmental, temperamental and educational problems in ‘substance use disorder’ patients with and without ADHD. Does ADHD make a difference? Addict Behav Rep. 2015;2:13-18.

van Emmerik-van Oortmerssen K, Vedel E, van den Brink W, Schoevers RA. Integrated

cognitive behavioral therapy for patients with Substance Use Disorder and comorbid ADHD: two case presentations Addict Behav. 2015;45:214-217.

Wapp M, van de Glind G, van Emmerik-van Oortmerssen K, Dom G, Verspreet S,

Carpentier PJ, Ramos-Quiroga JA, Skutle A, Bu ET, Franck J, Konstenius M, Kaye S, Demetrovics Z, Barta C, Fatséas M, Auriacombe M, Johnson B, Faraone SV, Levin FR, Allsop S, Carruthers S, Schoevers RA, Koeter MW, van den Brink W, Moggi F; IASP Research Group. Risk Factors for Borderline Personality Disorder in Treatment Seeking Patients with a Substance Use Disorder: An International Multicenter Study. Eur Addict Res. 2015;21(4):188-194.

Kaye S, Ramos-Quiroga JA, van de Glind G, Levin FR, Faraone SV, Allsop S, Degenhardt L, Moggi F, Barta C, Konstenius M, Franck J, Skutle A, Bu ET, Koeter MW, Demetrovics Z, Kapitány-Fövény M, Schoevers RA, van Emmerik-van Oortmerssen K, Carpentier PJ,

Dom G, Verspreet S, Crunelle CL, Young JT, Carruthers S, Cassar J, Fatséas M, Auriacombe M, Johnson B, Dunn M, Slobodin O, van den Brink W. Persistence and Subtype Stability of ADHD Among Substance Use Disorder Treatment Seekers. J Atten Disord. 2016. pii: 1087054716629217. [Epub ahead of print]

Konstenius M, Leifman A, van Emmerik-van Oortmerssen K, van de Glind G, Franck J,

(6)

247

List Of Publications

Barta C, Auriecomb M, Fatséas M, Johnson B, Faraone SV, Allsop S, Carruthers S, Schoevers RA, Verspreet S, Dom G, Koeter MW, van den Brink W. Childhood trauma exposure in substance use disorder patients with and without ADHD. Addict Behav. 2017;65:118-124.

van Emmerik-van Oortmerssen K, Vedel E, Kramer FJ, Koeter MW, Schoevers RA, van den

Brink W. Diagnosing ADHD during active substance use: Feasible or flawed? Drug Alcohol

Depend. 2017;180:371-375.

Submitted for publication / in preparation for submission:

van Emmerik-van Oortmerssen K, Vedel E, Kramer FJ, Blankers M, Dekker J, van den Brink

W, Schoevers RA. Integrated cognitive behavioral therapy for ADHD in adult substance use disorder patients: results of a randomized clinical trial. Submitted for publication.

van Emmerik-van Oortmerssen K, Blankers M, Vedel E, Kramer FJ, Goudriaan AE, van

den Brink W, Schoevers RA. Prediction of drop-out and outcome in integrated cognitive behavioral therapy for ADHD and SUD: Results from a randomized clinical trial. In preparation

for submission.

Dutch publications:

de Jonge A, de Beer F, van Oortmerssen K, Doreleijers Th. Kinder-en jeugdpsychiatrische

dagbehandeling. Een verkennend onderzoek naar de populatie en de werkwijze van een afdeling voor kinder- en jeugdpsychiatrische dagbehandeling gesitueerd op vier verschillende locaties. Tijdschrift voor Orthopedagogiek, Kinderpsychiatrie en Klinische Kinderpsychologie 2003; 28(2):63-72.

van Emmerik-van Oortmerssen K, Crunelle CL, Carpentier PJ. [Substance use disorders

and ADHD: an overview of recent Dutch research]. Tijdschr Psychiatr. 2013;55(11):861-866.

Book chapters:

Carpentier PJ, van Emmerik-van Oortmerssen K, Schoevers R. ADHD en verslaving. In:

Dom G, Dijkhuizen A, van der Hoorn B, Kroon H, Muusse C, van Rooijen S, Schoevers R, van Wamel A, eds. Handboek dubbele diagnose. Utrecht: De Tijdstroom; 2013: 281-296.

van Emmerik-van Oortmerssen K, Konstenius M, Schoevers RA. ADHD and Addiction.

In: Dom G, Moggi F, eds. Co-occurring addictive and psychiatric disorders: a practice-based

(7)

Referenties

GERELATEERDE DOCUMENTEN

The current study shows that a diagnosis of adult ADHD made at intake in treatment seeking SUD patients who are actively using substances, is a valid indicator for the presence

Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of

Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: Study protocol of

With regard to the prediction of treatment outcome in CBT/Integrated, we found that fewer baseline depression and anxiety symptoms and not using ADHD medication at baseline predicted

in the IASP that ADHD was more prevalent in patients with a drug use disorder (including cocaine and cannabis use disorders) than in patients with an alcohol use disorder, whereas

Ook werden de belangrijkste methodologische beperkingen van de studies besproken en werd aandacht besteed aan de klinische implicaties die voortvloeien uit dit onderzoek, waarvan

Ik maak hierbij ook graag van de gelegenheid gebruik om mijn (plaatsvervangend) opleiders, locatie-opleiders, en collega’s van GGZ Ingeest te bedanken, die mij alle steun

In 2009 she started working on a PhD program on the prevalence, diagnostic assessment and treatment of ADHD in SUD patients at Arkin in a collaboration with the Academic